These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22552384)

  • 1. Luminex and antibody detection in kidney transplantation.
    Picascia A; Infante T; Napoli C
    Clin Exp Nephrol; 2012 Jun; 16(3):373-81. PubMed ID: 22552384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC
    Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
    Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P
    Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation.
    Müller-Steinhardt M; Fricke L; Kirchner H; Hoyer J; Klüter H
    Clin Transplant; 2000 Feb; 14(1):85-9. PubMed ID: 10693642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: Luminex technology for HLA antibody detection in organ transplantation.
    Tait BD; Hudson F; Cantwell L; Brewin G; Holdsworth R; Bennett G; Jose M
    Nephrology (Carlton); 2009 Apr; 14(2):247-54. PubMed ID: 19207861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
    Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
    Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral Immune Response and Allograft Function in Kidney Transplantation.
    Filippone EJ; Farber JL
    Am J Kidney Dis; 2015 Aug; 66(2):337-47. PubMed ID: 25987262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
    Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT
    Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-HLA antibody detection and rejection in kidney transplantation: impact of the new technologies].
    Georgescu D; Ferrari-Lacraz S; Villard J
    Rev Med Suisse; 2007 Apr; 3(108):1064-9. PubMed ID: 17552259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.
    Taylor CJ; Kosmoliaptsis V; Summers DM; Bradley JA
    Hum Immunol; 2009 Aug; 70(8):563-8. PubMed ID: 19445992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
    Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
    Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.